Search

Your search keyword '"PHASE-2"' showing total 2 results
Start Over Descriptor "PHASE-2" Journal haematologica
2 results on '"PHASE-2"'

1. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice

Subjects
multiple myeloma, bortezomib, CELLS, toxicity, herpes zoster, KAPPA-B, PHASE-2
Abstract

The clinical data on the efficacy and toxicity of bortezomib as treatment for multiple myeloma patients are restricted to prospective phase II studies in expert myeloma centers. Here we report a multi-institutional analysis of the efficacy and toxicity of bortezomib in patients with relapsed or refractory multiple myeloma who were treated in community centers in a compassionate need program.

Published
2005

2. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice

Subjects
multiple myeloma, immune system diseases, hemic and lymphatic diseases, bortezomib, CELLS, toxicity, herpes zoster, KAPPA-B, PHASE-2
Abstract

The clinical data on the efficacy and toxicity of bortezomib as treatment for multiple myeloma patients are restricted to prospective phase II studies in expert myeloma centers. Here we report a multi-institutional analysis of the efficacy and toxicity of bortezomib in patients with relapsed or refractory multiple myeloma who were treated in community centers in a compassionate need program.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results